Pharmacovigilance system development

With amendments to Regulations (EC) 726/2004 and 520/2012 as well as Directive 2001/83/EC in recent years, the requirements for monitoring drug safety have become greatly formalised. The qualified person for pharmacovigilance (QPPV) is responsible for establishing and maintaining a company’s pharmacovigilance system.

We act in this capacity for pharmaceutical companies by performing a number of services, including the following:

  • Evaluation of existing pharmacovigilance activities (SOPs, literature research, reporting, PSURs, alarm plans, etc.) and measures to minimise risk
  • Establishing and summarising pharmacovigilance systems (pharmacovigilance system master file, PSMF) for pharmaceutical companies, including annexes
  • Compilation of risk management plans (RMP)
  • Conducting internal audits
  • Preparation for and assistance with inspections by regulatory authorities

Summary PSMF for marketing authorisation

A summary of the pharmacovigilance system master file (summary PSMF) and risk management plans are a necessary part of most applications for marketing authorisation. We can help compile and present the required documents completely and efficiently.

Dr. Tessa van Alen
Senior Consultant
Dr. Jasmin Beermann
Senior Consultant

File downloads

News

 

Contact us!
I agree to the privacy policy. I consent that reports related to products supported by Diapharm may be disclosed to a third party.
X

We are using cookies.

We use third party cookies for usage statistics and to further improve our website.